News
Pharma update: carve out generic pregabalin
On 15 January 2016 the Provisions Judge of the The Hague District Court handed down his decision in interim relief proceedings in the case of Warner-Lambert Company LLC vs. The State (Ministry of Health, CBG), ordering CBG (the Dutch MEB) to replace the online versions of the full label SmPC and PIL for generic pregabalin
Read more ›
Pharma update: Enforcement second medical use patent – new developments
In its interlocutory judgement of 25 November 2015 in the case Sun Pharmaceutical Industries (Europe) B.V. v. Novartis et al.the District Court of The Hague ruled that Sun has not indirectly infringed Novartis’ second medical use patent EP 1 2 96 689 (EP ‘689) relating to the treatment of osteoporosis. With its judgment, the District
Read more ›
Pharma update: Cross border injunction imatinib granted against Teva
In his decision of 30 March 2016 in the matter Novartis AG v Teva Nederland B.V. et al., the Provisions Judge of the District Court in The Hague held that Novartis is entitled to a Paediatric Extension for Glivec® (imatinib), based on Supplementary Protection Certificate no. 300086. The Provisions Judge has provisionally prohibited Teva to
Read more ›
Injunction against infringement of Permavoid patent
The District Court of The Hague has rendered judgment in the patent case Permavoid Ltd et al v HTW Installatietechniek B.V. on 7 January, 2015. Permavoid owns a European patent which regards the use of connected synthetic drainage modules as foundation replacement for vehicle trafficked pavements. The patented system is very popular for use in
Read more ›
